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For more information regarding this article, E-mail: christopher.cox@duke.edu choices, and reduce the use of high-cost procedures of unclear benefit (15, 16) . The importance of decision aids is underscored by their explicit promotion in the 2010 Affordable Care Act (17). However, decision aids have not been tested extensively in an ICU setting. The objective of this study was to develop a decision aid for surrogate decision makers of patients with prolonged mechanical ventilation, and to pilot test its feasibility, acceptability, and effect on decision-making quality and resource utilization.
MATERIALS AND METHODS

Study Design and Participants
In this study, we sequentially developed a decision aid, performed formative cognitive testing among decision-aid recipients, and compared the decision aid to usual care control using a prospective before (control)/after (decision aid) design ( Fig. 1) .
Study staff screened general surgical and trauma, neurological, cardiac, and medical ICUs daily. Consecutive subjects were eligible if they were ≥18 yrs of age and self-identified as being most involved in medical decision making for each patient mechanically ventilated for ≥10 days (a common definition for prolonged mechanical ventilation) (1) . We excluded surrogates of patients who had a tracheotomy placed for either emergency indications or for an ear, nose, or throat-related diagnosis; had preadmission tracheotomy; had been admitted for severe burns; had an expected survival <72 hrs or whose age <18 yrs. We also excluded surrogates who were not conversational in English. Surrogates received $25 for participation in this study. We enrolled the primary ICU attending physician at the time of patient eligibility. All study procedures took place at Duke University, Durham Regional Hospital, and the University of North Carolina between April 2009 and July 2010 ( Fig. 1 ).
Development of the Decision Aid
Decision Aid Content Derivation. We aimed to develop a decision aid that promoted the process of individualized shared decision making about whether to provide prolonged life support to a critically ill loved one (4) . Domain and quality criteria specified by International Patient Decision Aids Standards Collaboration guidelines guided decision aid development (18) . We defined the main decision about prolonged mechanical ventilation provision as a goal-based prioritization of patient-centered appropriate levels of treatment. The decision was presented as a continuum of options ranging from maximizing life prolongation to maximizing comfort; an intermediary area included a choice to aim for survival but avoid prolonged life support ( Fig. 2) (19) . We developed a list of key topics relevant to decision making, which were derived from inputs of experts in related topic areas (decision making, communication, geriatrics, palliative care, critical care outcomes, clinical medicine, and ethics), medical literature, and informal interviews with physicians and nurses. Decision-aid content was designed to address four main domains of shared decision making: providing medical information relevant to critical illness, eliciting surrogates' understanding of patient values and surrogates' role preferences, and guiding deliberation ( Fig. 3 ). It included information on treatments and procedures, as well as individualized probabilistic information on likely mortality, functional independence, and ultimate disposition derived from validated models of 1-yr survival and population-based prospective prolonged mechanical ventilation studies (1, 2) . The decision aid was designed to elicit both the surrogate's understanding of the patient's life support preferences and their preferred decision-making role through questions embedded within it (20) . The decision aid also aimed to guide deliberative decision making by prompting the surrogate to consider likely patient outcomes, the pros and cons of each option, the direction toward which they lean by taking a particular decision, and the additional questions that remained. Short explanatory stories were included to improve clarity. One investigator (CEC) compiled this information into an initial self-administered printed version that was ten pages long, written at a sixth-grade reading level, and made generous use of simple diagrams to illustrate key points as recommended by experts in decision making (21) . The decision was revised slightly after incorporating the feedback on clarity and completeness from 15 physicians and ten surrogates as well as from the group of experts.
Cognitive Testing. Trained research staff used a validated, semistructured, theory-based cognitive testing methodology to determine whether the decision aid was clear and understandable, contained acceptable information, and was useful in prolonged mechanical ventilation decision making (22) . Each page of the decision aid was reviewed by a study staff member along with surrogates; the staff member asked the surrogates open-ended questions about their general interpretation of the contents on each page as well as their importance and value to them. Physicians were interviewed in person on the day of the surrogate interview to obtain their estimate of 1-yr patient survival and to rate their acceptability of the decision aid.
Evaluation of the Decision Aid vs. Usual Care Control
Overview. Surrogates and physicians completed identical study questionnaires in person on the day of enrollment but before the intervention, as well as within 2 days after a familyphysician meeting. Intervention surrogates reviewed the decision aid after enrollment, and were briefly instructed in its use by study staff; surrogates kept the decision aid throughout the study period. Control surrogates received no additional information. Participants in both groups were scheduled to attend an ICU physician-family meeting within 2 days of enrollment, generally coinciding with 2 wks postintubation. The study protocol did not specify the content of this unstructured meeting, requesting only that physicians ask intervention surrogates if they had any questions about the decision aid content.
Data Collection and Outcomes Measures. We collected data from in-person interviews as well as from patients' medical charts including diagnoses at admission, sociodemographics, Charlson comorbidity scores (23), limitations in activities of daily living (24, 25) , acute physiology scores (Acute Physiology and Chronic Health Evaluation II) (26), quality of life (Euro Quality of Life 5-Dimension Scale) (27) , symptoms of anxiety and depression (Hospital Anxiety and Depression Scale) (28), mechanical ventilation duration and outcome, and hospital and ICU lengths of stay.
The primary outcomes were physiciansurrogate discordance for expected 1-yr patient survival, quality of communication with physicians, and medical comprehension. The validated physician-surrogate discordance score was calculated as the absolute difference between physicians' and surrogates' prognostic estimates for 1-yr patient survival on a 0%-100% scale (8, 29) . Discordance scores could range from 0 (maximal concordance) to 100 (maximal discordance). Physician-surrogate communication was characterized using the Quality of Communication scale, a validated 17-item (mean score range 0 [worst]-10 [best]) instrument (30) . Surrogates' understanding of diagnosis, prognosis, and treatments was assessed using a 12-item (score range 0 [poor comprehension]-12 [excellent comprehension]) adapted version of the medical comprehension scale (7) . Satisfactory comprehension for each item was defined as either correct identification of each relevant factor or prognostic estimate within +/−25% of physicians' estimates. The decisional conflict scale, a 16-item instrument (lower scores reflecting more uncertainty) was used to evaluate decisional uncertainty (31) . The feasibility of adopting the decision aid was assessed using enrollment rates and acceptability was measured by querying subjects about whether the decision aid was an acceptable way to approach the prolonged mechanical-ventilation decision (agree/disagree). Secondary outcomes were measured using single-item, Likert scale (strongly agree, agree, uncertain, disagree, strongly disagree) measures of surrogates' trust of ICU physicians, conflict with physicians, and whether physicians discussed patients' expected 1-yr survival and functional status. Total hospital costs were gathered from administrative databases.
Statistical Analyses. We chose a sample size that represented a reasonable sample (roughly 15%) of ICU patients at our institutions who receive prolonged mechanical ventilation, with group division chosen to achieve a 1:1.5 control to intervention ratio. Categorical data are presented using number (percentage) and continuous data as means (standard deviations) or medians (interquartile ranges). For the prospective evaluation of the decision aid to control, we used analysis of covariance tests to compare postintervention differences in the primary outcomes within the subjects between control and decision aid groups after verifying normality assumptions with Shapiro-Wilk tests, incorporating baseline questionnaire scores in regression equations (32) . For secondary outcomes, we compared study groups using Fisher's exact tests for categorical variables and either Kruskal-Wallis tests or t tests for continuous variables. Because cost data were skewed, we used generalized linear models with a gamma distribution and a logarithmic link function to compare total hospital costs by study group (33, 34) . We used Stata, version 11 (College Station, TX) for all analyses and considered a p < .05 to be significant. Institutional Review Boards at all study sites approved the study procedures. Portions of these data have been presented previously in abstract form (35) .
RESULTS
Cognitive Testing
Sixteen surrogate decision makers and corresponding patients' 16 primary ICU-attending physicians participated in formative cognitive testing of the decision aid. Surrogates were diverse in age (range 44-70 yrs), sex (55% female), and ethnicity (27% non-white). All reported that the decision aid was useful in understanding prognosis and treatment options and in motivating them to engage in discussions with the medical team about treatment options including palliative care; none reported associated psychological distress. All physicians reported that the decision aid was acceptable and complementary to family meetings. Prior to viewing the decision aid, only 2 surrogates (12%) could correctly estimate patients' 1-yr survival within 25% of the physician's estimate, whereas afterward, all 16 (100%) could do so correctly. Furthermore, before viewing the decision aid no surrogates could articulate any specific goals of treatment other than "survival," yet afterward all 16 (100%) accurately described the three goals of treatment presented. Minor revisions based on participant critiques were subsequently incorporated in the final decision aid (see Supplemental Digital Content 1, http://links.lww.com/CCM/A477).
Evaluation of the Decision Aid vs. Usual Care Control
Baseline Characteristics and Hospital Course. In the prospective evaluation, a total of ten surrogate decision makers received usual care and 17 received the decision aid; three surrogates refused participation. Surrogates were younger and mostly female. Most surrogates reported symptoms of either depression (85%) or anxiety (70%) on the day of enrollment. There were no statistically significant between-group differences in sociodemographic characteristics or psychological distress ( Table 1) . Patients were generally elderly, male, and possessed a number of chronic medical comorbidities; few, however, had baseline dependencies in activities of daily living. There were no clinically important between-group differences in the pre-enrollment length of stay. Attending physicians were from both medical (74%) and surgical (26%) services; no physicians refused participation.
Outcomes. Compared to control, decision aid recipients had lower postintervention physician-surrogate discordance , p = .004) ( Fig. 4) . Decision aid recipients also had lower physician-surrogate discordance for 1-yr functional independence (7 [6] vs. 38 [32] , p = .011).
Secondary outcomes are shown in Table 2 . Compared to control, decision aid surrogates reported more frequent discussions with physicians about expected long-term patient survival and functional status (both p = .013). A trend toward improved physician trust and physician conflict was observed in the intervention group, though this was not statistically significant. Three control patients (30%) and 10 intervention patients (59%) had a change in advance directive status during the study (p = .15). Total hospital costs were lower in the decision aid group ($110,609 vs. $178,618; p = .044), a finding possibly explained by lower costs for ICU room (p = .098), respiratory therapy (p = .086), and pharmacy (p = .002). Decision aid group patients had numerically fewer ventilator days, ICU days, and hospital days, though these differences were not statistically significant. There were no clinically important group differences in discharge disposition or hospital mortality.
Intervention feasibility was demonstrated by the high enrollment rate of eligible subjects (90%), the fact that all family meetings were held within 2 days of enrollment (70% within 24 hrs), and our observation that all subjects were able to review the decision aid within an hour with ≤ 15 mins of staff support. Support for the acceptability of the intervention was demonstrated by the report of 16 surrogates (94%) that the decision aid was useful in the decision-making process; one surrogate felt unprepared to receive the information contained in the decision aid. All physicians reported that the decision aid was useful and that its discussion in a family meeting setting was acceptable.
DISCUSSION
In this pilot study among surrogate decision makers of patients with prolonged mechanical ventilation, we developed a decision aid that was feasibly administered, well accepted by surrogates and physicians, and associated with improved decision-making quality. Compared to usual care control, the decision aid was associated with improved physician-surrogate concordance for longterm survival, quality of communication, and medical comprehension, as well as reduced decisional conflict. Given the trend toward lower length of stay in the intervention group, there is a suggestion that the decision aid may expedite the decision-making process, thereby reducing resource utilization.
Problems with ICU decision making have been reported for decades. Medical information including prognosis is often not shared by physicians, is inaccurate, and is poorly understood by surrogates (7-9, 12, 36-38) . This is particularly true in prolonged mechanical ventilation, in which unrealistically optimistic prognostication among physicians and surrogates is common (8) . These communication deficiencies can impair comprehension, increase discordance and conflict, and threaten the patient-centeredness of the decision itself (8, 39) .
This decision aid is one of the first ICU-based interventions to address specific deficiencies in informed decision making. It also has potential to improve the process of shared decision making, a model widely endorsed by consensus groups but uncommonly implemented in clinical practice (5, 40) . The decision aid explicitly promotes shared decision making by providing medical information, eliciting surrogate decision makers' understanding of patient preferences and their preferred decision role, and guiding deliberation (6) . In doing so, the decision aid aims to stimulate collaborative communication between physicians and surrogates, therefore addressing sources of potential conflict and distrust. The decision aid also represents a pragmatic approach that could be easily disseminated and inexpensively implemented in clinical practice. Additionally, it targets risk factors for greater length of stay by encouraging more timely "in the moment" decision making, improving physician time efficiency, and focusing on causes of surrogate-physician discordance and conflict (2, 39, 41) . By acting as an adjunct to the decision-making process, the decision aid also addresses the time constraints of an ICU workforce gap that will continue to widen in the future (42) . Furthermore, the decision aid has the potential to improve long-term surrogate decision maker outcomes because it addresses risk factors for psychological distress including physician-surrogate discordance, poor communication and comprehension, multiprovider contradictions, inadequate medical information provision, and elicitation of preferred decisional roles (7, 13, 43) .
Our study has several limitations. First, the complexity and individuality of ICU decision making cannot be distilled completely into a decision aid that at best represents an adjunctive tool in the surrogate-physician dynamic. The decision aid is not a replacement for good quality communication and does not address all important end of life issues confronting providers such as communication skills training, fundamental values conflicts, prognostic uncertainty, and patients who lack surrogate decision makers. Second, it may be challenging to implement the decision aid in different populations and care locations. Specifically, the intervention does not address many of the diverse range of educational, linguistic, ethnic, cultural, and religious characteristics that may influence surrogates' decisions and may not address all outcomes of importance to decision makers (44) (45) (46) . Future versions of the decision aid could be written at an even lower reading level, translated into other languages, and adapted to include local sociocultural factors that weigh heavily in decision making. Third, because print-based decision aids have limited flexibility in adapting to different user information needs, we are currently evaluating a web-based format that could also allow widespread, inexpensive access to decision support (47) . Fourth, generalizations about the intervention's benefit are limited by the modest sample size, quasi-experimental design, and potential differences in casemix and temporal trends. Group-based cost differences appear generally related to length of stay, though the notable signal associated with pharmacy costs may suggest a more specific focus on postintervention simplification of management. More detailed study is required with longterm follow-up to determine whether the decision aid reduces resource utilization, and if so, through what mechanisms. Because family meetings were not recorded, we are unable to assess how the decision aid may have affected the surrogate-physician interaction itself. A randomized controlled trial is needed to determine its efficacy.
CONCLUSION
We found that a novel decision aid for surrogate decision makers of patients with prolonged mechanical ventilation was feasible and acceptable, may improve the quality of ICU decision making, and reduce resource utilization. Additional research is needed to determine the decision aid's true effectiveness and its impact on long-term outcomes.
